PI3K and/or mTOR inhibitor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9365572
APP PUB NO 20150239885A1
SERIAL NO

14427665

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt, a stereoisomer or a solvate thereof, wherein R1, R2, R3, R4, X, Y, A and B are as defined in the specification. The present invention further relates to a method for preparing these compounds, a pharmaceutical composition containing these compounds, and a use of these compounds in manufacture of a medicament for treating and/or preventing proliferative diseases.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
XUANZHU PHARMA CO LTD2518 TIANCHEN STREET NATIONAL HIGH-TECH DEVELOPMENT ZONE JINAN-CITY SHANDONG PROVINCE 250101

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Shu, Chutian Jinan, CN 16 21
Wu, Frank Jinan, CN 101 2813

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 14, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00